EPIDERMAL GROWTH FACTOR RECEPTOR
Clinical trials for EPIDERMAL GROWTH FACTOR RECEPTOR explained in plain language.
Never miss a new study
Get alerted when new EPIDERMAL GROWTH FACTOR RECEPTOR trials appear
Sign up with your email to follow new studies for EPIDERMAL GROWTH FACTOR RECEPTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Spinal injection offers hope for lung Cancer's worst brain complication
Disease control Recruiting nowThis study is testing a new combination treatment for a serious complication where lung cancer spreads to the lining of the brain and spinal cord. It involves injecting a chemotherapy drug directly into the spinal fluid, alongside a targeted oral medication, for patients whose pr…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE2 • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control
Last updated Apr 01, 2026 20:11 UTC
-
First patients to receive new cancer drug in groundbreaking safety trial
Disease control Recruiting nowThis is the first-ever study in people for a new drug called EPI-326. It aims to find a safe dose and see how the body handles the drug in patients with advanced lung cancer (with a specific genetic change called EGFR mutation) or advanced head and neck cancer. The main goal is t…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New approach aims to extend control of advanced lung cancer
Disease control Recruiting nowThis study is looking at whether adding surgery or radiation to the primary lung tumor can help people with advanced, EGFR-mutant lung cancer live longer without their cancer getting worse. It is for patients whose cancer has been controlled by a specific combination of drugs. Th…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE2 • Sponsor: Pusan National University Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New scan aims to see inside deadly brain tumors
Knowledge-focused Recruiting nowThis study is testing a new type of combined MRI and PET scan to see if it can accurately measure how brain tumor cells use energy (a process called glycolysis). Researchers will compare scan results from 50 adults with glioblastoma to actual tissue samples taken during their pla…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC